Looking Forward Post 2016 Political Elections

By Dr. Alan S. Louie – November 15, 2016
Photo of Dr. Alan S. LouieOffline

While the healthcare industry is most visibly targeted with the promise to repeal Obamacare, the life science industry can expect to experience significant changes in the shadow of the 2016 elections.

The life science analyst team plans on diving more deeply into the topic over the next several weeks, but our high level view is that repatriation of off-shore revenue, weakening of the FDA, re-importation of drugs, and easing of calls for drug price controls will drive early, life science-related Trump presidency discussions and actions.

The quote "May you live in interesting times," is more relevant than ever. Stay tuned. As always, comments and alternative opinions are always welcome and appreciated.


About the author

Dr. Alan S. Louie

Research DirectorIDC Health Insights

Dr. Alan Louie is Research Director at IDC Health Insights. In this role, he is spearheading the company’s research covering innovation and best practices in pharmaceutical R&D and personalized…


Post a comment

Form Signatures

Viewed 3,441 times